|
|
|
Naturex, the French multinational corporation in which Natraceutical holds a 35% stake, discloses their 2009 turnover.
(191,96 Kb)
|
|
|
|
|
|
The Spanish Ministry of Science and Innovation has approved an R+D project by Natraceutical Group within the CENIT Programme.
(935,83 Kb)
|
|
|
|
|
|
Natraceutical Group issue their third quarter results.
(608,27 Kb)
|
|
|
|
|
|
Natraceutical signs a strategic alliance with BioNike for the penetration of Forté Pharma in Italy and the entry into the cosmeceutic market.
(219,68 Kb)
|
|
|
|
|
|
|
Natraceutical Group has started negotiations with the main creditor entities to refinance the financial debt and carry out its restructuring process.
(122,64 Kb)
|
|
|
|
|
|
Natraceutical Group and publicly-traded French company Naturex reach an agreement to create a world leading company of natural ingredients.
(72,01 Kb)
|
|
|
|
|
|
Natraceutical Group issue their 1st quarter results.
(310,21 Kb)
|
|
|
|
|
|
Natraceutical Group appoints Julien Laporte General Manager of the Food Supplement Division.
(237,58 Kb)
|
|
|
|
|
|
|
Natraceutical Group closes 2008 with 5.3% growth in sales ans 13.6% in EBITDA in a year of streamlining of their industrial structures.
(248,57 Kb)
|
|
|
|
|
|
Natraceutical Group further improves its performance ratios with 7.5% EBITDA growth and 17% recurrent earnings.
(96,59 Kb)
|
|
|
|
|
|
|
UK study contributes new evidence on the benefits of pectin agains cancer, of which Natraceutical is the sixth world-wide producer.
(192,47 Kb)
|
|
|
|
|
|
Grupo Kiluva increases its stake in Natraceutical up to 7,51%.
(185,43 Kb)
|
|
|
|
|
|
Natraceutical Group registers the patent for a new naturally-sourced bioactive compound featuring antihypertensive and anti-degenerative properties.
(78,76 Kb)
|
|
|
|
|
|
Natraceutical Group creates a personalized online coaching service on health, wellness and beauty.
(245,65 Kb)
|
|
|
|
|
|
Natraceutical Group's net profit rose 13.6% during the first half of 2008.
(305,54 Kb)
|
|
|
|
|
|
Natraceutical Group and the Swiss company Bühler have united their technology and commercial capacity in a unique joint development in their sector.
(103,77 Kb)
|
|
|
|
|
|
Natraceutical Group increases EBITDA by 25% and net profit by 40% in the first quarter of 2008.
(103,69 Kb)
|
|
|
|
|
|
|
Natraceutical expands the body of directors to reinforce the upcoming plans of expansion.
(99,95 Kb)
|
|
|
|
|
|
2007 marks the consolidation of Natraceutical Group fuelled by strong organic growth and recent acquisitions.
(143,48 Kb)
|
|
|
